Artemis Medicare

Q1 FY27Healthcare Services

Artemis Medicare Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹341

Market cap₹5.4K Cr

P/E46.4

Updated23 Sept 2026

Read4 min read

What the Q1 FY27 call signalled

4 of 5 strong

RevenueGood growth

MarginMargins steady

CapexCapex planned

FundraiseFundraise planned

Order bookOrder book rising

The short version

Expansion to 900-950 beds at Gurgaon standalone facility in 18-22 months. Artemis Medicare Services projects reaching 70% occupancy by Q2 FY27, boosting revenue and profitability.

From Artemis Medicare's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.

Revenue & Sales Performance

Good growth

Expansion to 900-950 beds at Gurgaon standalone facility in 18-22 months.
Target occupancy of 70% by Q2 and 85% census in the medium term.
Anticipated 4-5% ARPOB (Average Revenue Per Occupied Bed) growth.
Potential to reach INR 2,000 crores topline from Gurgaon alone within 3-5 years.
Launch of advanced tertiary and quaternary pediatric and obstetric care in new 200-bed expansion.
Raipur facility showing encouraging early traction with multiple specialties active, growing OPD and surgery volumes.
Focus on brownfield expansions via internal accruals and selective acquisitions (INR 700 crores enabling resolution).

2 more points management made on revenue & sales performance

Profitability & Margins

Artemis Medicare Services projects reaching 70% occupancy by Q2 FY27, boosting revenue and profitability.
Expansion plans include increasing beds to 900-950 in Gurgaon within 18-22 months, targeting INR 2,000 crores topline in 3-5 years based on 85% census, 70% occupancy, and 4-5% ARPOB growth.
Expect operating margins to improve to upwards of 23%, driven by economies of scale and advanced tertiary and quaternary care services.
The new 200-bed Tower IV expansion in Gurugram aims to break even within 8-10 months and reach 50%-60% utilization within six months post-launch.
Q1 FY27 showed EBITDA margin at 21.5%, with FY27 margins in Gurgaon expected between 20%-21%, and 23%-24% within 2-3 years.

2 more points management made on profitability & margins

See what Artemis Medicare said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned

Total capex planned over the next three years is approximately INR 800 crores, excluding deposits.
Breakdown includes:
INR 120 crores for Tower IV (200-bed expansion in Gurgaon with multi-level parking).
INR 350-360 crores for VIMHANS hospital expansion.
INR 120 crores for Raipur hospital (already operational).
Additional deposit of INR 250 crores to VIMHANS, with INR 130 crores already paid.
A 200+ bed advanced pediatric and obstetrics/gynecology facility to be operational in 18-22 months.
Enabling resolution passed to raise up to INR 700 crores for potential brownfield acquisitions and strategic expansions, expected to be decided within 6-8 months based on asset finalization.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Artemis Medicare Services Limited has an enabling resolution for raising up to INR 700 crores, primarily intended for acquisition-related financing, especially for brownfield projects (Page 14, 15, 16, 17).
The timing for this proposed QIP (Qualified Institutional Placement) is expected to be around 6 to 8 months after finalizing target assets (Page 12).
The amount and timing of the fundraising will be carefully decided based on asset quality, shareholder dilution concerns, and return on investment; management aims for minimum dilution (Page 15, 17).

Current internal accruals and debt leverage cover significant portions of ongoing capex (INR 800 crores over three years), including deposits already paid to VIMHANS, indicating partial funding is already secured without immediate additional raising (Page 14, 15, 16, 17).
Decisions on raising from equity or debt will be made after asset finalization with full transparency to shareholders (Page 15).

2 more points management made on fundraising & capital structure

See what Artemis Medicare said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Order book rising

The transcript does not explicitly mention a current or expected order book or pending orders for Artemis Medicare Services Limited. However, related information includes: - INR 800 crores of capex lined up for the next three years, excluding a separate INR 250 crores deposit for VIMHANS. - Internal accruals expected to generate around INR 150 crores per year, totaling around INR 450 crores over three years. - INR 700 crores enabling resolution approved for potential brownfield projects and equity expansion over three years. - Expansion includes 200+ beds addition at Gurgaon facility, expected operational in 18-22 months.

2 more points management made on order book & pipeline

Artemis Medicare — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹274 Cr, net profit ₹30 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Artemis Medicare's management said in earlier quarters

Others in Healthcare Services this season

KMC Speciality Hospitals (India) Ltd (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
3B Blackbio DX Ltd (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Thyrocare Technologies Ltd (Q1 FY27)
Pathology business grew ~27%; franchisee business grew ~23-27% YoY, reflecting strong volume growth. Key concall takeaways from Thyrocare Technologies Ltd's Q1…
Krsnaa Diagnost. (Q1 FY27)
. Key concall takeaways from Krsnaa Diagnost.'s Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Artemis Medicare Q1 FY27 results?

Expansion to 900-950 beds at Gurgaon standalone facility in 18-22 months. Artemis Medicare Services projects reaching 70% occupancy by Q2 FY27, boosting revenue and profitability.

What is Artemis Medicare share price analysis?

Artemis Medicare currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 46.4 with a market cap of ₹5,359 Cr. Investors should review the full earnings analysis for detailed insights.

Is Artemis Medicare planning capital expenditure?

Total capex planned over the next three years is approximately INR 800 crores, excluding deposits.

Keep Artemis Medicare on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.